Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Escherichia coli (E. coli) genome is the complete genetic material of the bacterium E. coli, typically a single, circular DNA molecule. It encodes all information necessary for cellular function, replication, and adaptation. The genome is organized into macrodomains and plectonemic loops. Significant strain-level diversity arises from horizontal gene transfer, resulting in mosaic genome structures. The genome contains protein-coding genes, tRNA genes, rRNA operons, insertion sequences, prophage remnants, and plasmids (in some strains), contributing to plasticity and adaptability. Understanding the E. coli genome is crucial for studying bacterial pathogenesis, antibiotic resistance, and developing targeted antimicrobial strategies.
N/A
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli Genome (E. coli Genome).